Inhibrx Biosciences, Inc. (INBX) has a market capitalization of $1.22B and trades at $83.19. The 52-week range is 10.805-94.565.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.2, Earnings Per Share (EPS) of $-9.04, annual revenue of $1.3M.
The stock has a beta of 1.51, a last dividend of $0.8500, operates in the Healthcare sector.
